Arun S Shet
Overview
Explore the profile of Arun S Shet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
34
Citations
853
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Phillips A, Segovia L, Livinski A, Wilson C, Shet A, Bevans M
Womens Health Rep (New Rochelle)
. 2025 Jan;
5(1):973-983.
PMID: 39758526
Although there is an emerging body of evidence that addresses the adverse health outcomes of individuals with sickle cell trait (SCT), it is not clear if the findings are generalizable...
2.
Quang T, Mostashari G, Berning E, Gopalan B, Lizarralde-Iragorri M, Lovins D, et al.
Biomed Opt Express
. 2024 Sep;
15(8):4829-4841.
PMID: 39346999
The goal of this study is to identify non-invasive optical hemodynamic biomarkers that can index laboratory hematology measurements in sickle cell disease (SCD). We acquired frequency-domain NIRS (FD-NIRS) and diffuse...
3.
Singh A, Brousseau D, Dasgupta M, Shet A, Field J, Brandow A
PLoS One
. 2024 Apr;
19(4):e0297469.
PMID: 38626063
Cardiopulmonary and renal end organ (CPR) complications are associated with early mortality among individuals with sickle cell disease (SCD). However, there is limited knowledge regarding acute care utilization for individuals...
4.
Lizarralde-Iragorri M, Gopalan B, Merriweather B, Brooks J, Hill M, Lovins D, et al.
Blood Adv
. 2023 Dec;
8(1):172-182.
PMID: 38157227
Data from a small trial in patients with cancer suggest that isoquercetin (IQ) treatment lowered thrombosis biomarkers and prevented clinical thrombosis, but, to our knowledge, no studies of IQ have...
5.
6.
Singh A, Brandow A, Wun T, Shet A
Blood Adv
. 2022 Jun;
6(15):4408-4412.
PMID: 35763429
Venous thromboembolism (VTE) is a life-threatening complication observed among patients with sickle cell disease (SCD) and also among those with severe COVID-19 infection. Although prior studies show that patients with...
7.
Tumburu L, Ghosh-Choudhary S, Seifuddin F, Barbu E, Yang S, Ahmad M, et al.
Blood
. 2021 Mar;
137(22):3116-3126.
PMID: 33661274
The pathophysiology of sickle cell disease (SCD) is driven by chronic inflammation fueled by damage associated molecular patterns (DAMPs). We show that elevated cell-free DNA (cfDNA) in patients with SCD...
8.
Shet A, Lizarralde-Iragorri M, Naik R
Haematologica
. 2020 Oct;
105(10):2368-2379.
PMID: 33054077
The genetic and molecular basis of sickle cell disease (SCD) has long since been characterized but the pathophysiological basis is not entirely defined. How a red cell hemolytic disorder initiates...
9.
Strader M, Jana S, Meng F, Heaven M, Shet A, Thein S, et al.
Sci Rep
. 2020 Aug;
10(1):14218.
PMID: 32848178
Intracellular oxidative stress and oxidative modification of sickle hemoglobin (HbS) play a role in sickle cell disease (SCD) pathogenesis. Recently, we reported that Hb-dependent oxidative stress induced post-translational modifications (PTMs)...
10.
Lizarralde-Iragorri M, Shet A
Int J Mol Sci
. 2020 Jul;
21(15).
PMID: 32722421
Venous thromboembolism (VTE) is an important cause of vascular morbidity and mortality. Many risk factors have been identified for venous thrombosis that lead to alterations in blood flow, activate the...